TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32745229

Group type: EXPERIMENTAL
Intervention: Gravity-Assisted Passive Flexion (GAP-FLEX)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Continuous Passive Motion (CPM)
Number of subjects: 27
Study: 37409839

Group type: EXPERIMENTAL
Intervention: Mozart sonatas
Number of subjects: 20

Group type: COMPARATOR
Intervention: No music (control)
Number of subjects: 20
Study: 34079227

Group type: EXPERIMENTAL
Intervention: Dezocine 0.8 mg/kg (Group D)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sufentanil 2 µg/kg (Group S)
Number of subjects: 60
Study: 32159530

Group type: EXPERIMENTAL
Intervention: Free gingival graft (FGG)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Collagen matrix
Number of subjects: 63

Group type: COMPARATOR
Intervention: Apically positioned flap (control group)
Number of subjects: 63
Study: 34786695

Group type: EXPERIMENTAL
Intervention: Case management and education from patient navigators (PNs)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Control arm (specialty care alone)
Number of subjects: 224
Study: 32112353

Group type: EXPERIMENTAL
Intervention: Higher intensity home-based aerobic exercise intervention for 5-12 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 34
Study: 35061795

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing Social Network Intervention (MI-SNI)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 41
Study: 33238763

Group type: EXPERIMENTAL
Intervention: Super Pulse Thulium Fiber Laser (SP TFL)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Holmium Laser (Ho:YAG)
Number of subjects: 174
Study: 32918588

Group type: EXPERIMENTAL
Intervention: High-Volume Low-Intensity Training (HVLIT)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: High-Frequency Training (HFT)
Number of subjects: 13

Group type: COMPARATOR
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Overall response to mesocycles
Number of subjects: 13
Study: 36380008

Group type: EXPERIMENTAL
Intervention: Bilateral erector spinae plane block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wound infiltration
Number of subjects: 60
Study: 32909365

Group type: EXPERIMENTAL
Intervention: 180 mg of Ellagic acid per day
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 32641142

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT) in addition to conventional therapy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional treatment including medication therapy and invasive interventional therapy
Number of subjects: 98
Study: 34905411

Group type: EXPERIMENTAL
Intervention: Healthy Lifestyle Summer Camp and Parenting program (HLSC+HLPP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healthy Lifestyle Summer Camp (HLSC)
Number of subjects: 24
Study: 32307431

Group type: EXPERIMENTAL
Intervention: Mexidol (500 mg IV once daily for 14 days, then Mexidol Forte 250 (250 mg, 3 times a day for 60 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard basic therapy (comparison group)
Number of subjects: 50
Study: 35414517

Group type: EXPERIMENTAL
Intervention: 5* GRIP-rated slip-resistant footwear
Number of subjects: 4553

Group type: COMPARATOR
Intervention: Usual work footwear (Control)
Number of subjects: 4553
Study: 35258839

Group type: EXPERIMENTAL
Intervention: TA-ER 32 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: TAcs 40 mg
Number of subjects: 30
Study: 34927787

Group type: EXPERIMENTAL
Intervention: Hypertensive disorders of pregnancy (HDP)
Number of subjects: 2718

Group type: COMPARATOR
Intervention: Normotensive
Number of subjects: 2718
Study: 34531416

Group type: EXPERIMENTAL
Intervention: Neurofeedback training (NFT) group (n=25)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (n=23)
Number of subjects: 48
Study: 34620545

Group type: EXPERIMENTAL
Intervention: Self-efficacy to obtain sexual consent (females)
Number of subjects: 2291

Group type: EXPERIMENTAL
Intervention: Communication about condom use (females)
Number of subjects: 2291

Group type: EXPERIMENTAL
Intervention: Communication about HIV prevention (females)
Number of subjects: 2291

Group type: EXPERIMENTAL
Intervention: HIV/sexually transmitted infection prevention communication (Black and other race students)
Number of subjects: 2291

Group type: EXPERIMENTAL
Intervention: Consistent condom use (students with high self-efficacy and communication)
Number of subjects: 2291
Study: 32056985

Group type: EXPERIMENTAL
Intervention: High-intensity negative ion patch treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32483770

Group type: EXPERIMENTAL
Intervention: Desmopressin (0.3 μg/kg)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: LPS (2 ng/kg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9%)
Number of subjects: 31
Study: 32746071

Group type: EXPERIMENTAL
Intervention: Adaptive training using the proposed curriculum
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group self-managing the training session
Number of subjects: 24
Study: 32450915

Group type: EXPERIMENTAL
Intervention: SOC plus hydroxychloroquine monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SOC plus hydroxychloroquine and azithromycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: SOC alone
Number of subjects: 0
Study: 34993571

Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced high-protein diet (CRHP, E%: CH30/P30/F40)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional diabetes diet (CD, E%: CH50/P17/F33)
Number of subjects: 72
Study: 34085588

Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo tape
Number of subjects: 54

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 54
Study: 32503948

Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 2261

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 2261
Study: 36014930

Group type: EXPERIMENTAL
Intervention: eHealth lifestyle coaching programme
Number of subjects: 170

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 170
Study: 33549732

Group type: EXPERIMENTAL
Intervention: Music therapy intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 100
Study: 32843527

Group type: EXPERIMENTAL
Intervention: PIK3CA mutated tumors
Number of subjects: 1253

Group type: COMPARATOR
Intervention: PIK3CA wild-type tumors
Number of subjects: 1253

Group type: EXPERIMENTAL
Intervention: HER2-enriched/PIK3CA mutated tumors
Number of subjects: 1253

Group type: COMPARATOR
Intervention: HER2-enriched/PIK3CA wild-type tumors
Number of subjects: 1253

Group type: EXPERIMENTAL
Intervention: High TILs (10% increment)
Number of subjects: 1253

Group type: EXPERIMENTAL
Intervention: PDCD1 expression
Number of subjects: 1253

Group type: EXPERIMENTAL
Intervention: MYBL2 expression
Number of subjects: 1253
Study: 35779110

Group type: EXPERIMENTAL
Intervention: Behavioral therapy (BT) + pelvic floor muscle training (PFMT) + anticholinergic + beta3‐agonist
Number of subjects: 70

Group type: COMPARATOR
Intervention: Behavioral therapy (BT) + anticholinergic + beta3‐agonist
Number of subjects: 70
Study: 34969300

Group type: EXPERIMENTAL
Intervention: Research data informed an opera on Veteran recovery
Number of subjects: 280
Study: 35851816

Group type: EXPERIMENTAL
Intervention: Deconstruction into key steps (DIKS)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard course (Control Group)
Number of subjects: 126
Study: 34334330

Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Ibrutinib with Rituximab (IR)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Bendamustine-Rituximab (BR)
Number of subjects: 53
Study: 35548067

Group type: EXPERIMENTAL
Intervention: Same-day discharge (SDD) group
Number of subjects: 84

Group type: COMPARATOR
Intervention: Inpatient group
Number of subjects: 84
Study: 32166544

Group type: EXPERIMENTAL
Intervention: Systemic sedoanalgesia (intravenous remifentanil/fentanyl ± intravenous midazolam ± intravenous acetaminophen/nonsteroidal anti‐inflammatory drugs) + subcutaneous anesthesia (lidocaine)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Mild systemic sedoanalgesia (oral solution morphine sulfate + intravenous midazolam + intravenous acetaminophen) + both subcutaneous and subcapsular anesthesia (mepivacaine + bupivacaine)
Number of subjects: 14
Study: 616854037

Group type: EXPERIMENTAL
Intervention: Ear Acupuncture (EA) for 20 min
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo group (PG) treated with detuned ultrasound
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ear Acupuncture (EA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo group (PG)
Number of subjects: 80
Study: 33802381

Group type: COMPARATOR
Intervention: Resveratrol (lower dose)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Resveratrol (higher dose)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Luteolin (lower dose)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Luteolin (higher dose)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Fisetin (lower dose)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Fisetin (higher dose)
Number of subjects: 21
Study: 32126490

Group type: EXPERIMENTAL
Intervention: Brain-responsive neurostimulation (RNS® System)
Number of subjects: 191
Study: 34958337

Group type: EXPERIMENTAL
Intervention: Sports Stars Brazil (modified sports intervention)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 76
Study: 35102967

Group type: EXPERIMENTAL
Intervention: 4% articaine buccal infiltration
Number of subjects: 46

Group type: COMPARATOR
Intervention: 2% lignocaine inferior alveolar nerve block (IANB)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Behavior assessment
Number of subjects: 46
Study: 32470438

Group type: EXPERIMENTAL
Intervention: Deferiprone (75-100 mg/kg per day)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Deferasirox (20-40 mg/kg per day)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Deferiprone
Number of subjects: 393

Group type: COMPARATOR
Intervention: Deferasirox
Number of subjects: 393
Study: 35543129

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase
Number of subjects: 9
Study: 34452714

Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Classic group (control)
Number of subjects: 196
Study: 34313812

Group type: EXPERIMENTAL
Intervention: Tofacitinib (TOF) 5 mg orally twice a day
Number of subjects: 66

Group type: COMPARATOR
Intervention: Methotrexate (MTX) 10 mg weekly
Number of subjects: 66
Study: 33055139

Group type: EXPERIMENTAL
Intervention: Hybrid Closed-Loop (HCL)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (user-determined insulin dosing)
Number of subjects: 120
Study: 35940596

Group type: EXPERIMENTAL
Intervention: Plastic drape
Number of subjects: 14

Group type: COMPARATOR
Intervention: No drape (control)
Number of subjects: 14
Study: 34077237

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with modified oxaliplatin, leucovorin, and fluorouracil (FOLFOX)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with carboplatin‐paclitaxel (CP)
Number of subjects: 241

Group type: COMPARATOR
Intervention: PET nonresponders who crossed over to CP after induction FOLFOX
Number of subjects: 241

Group type: COMPARATOR
Intervention: PET nonresponders who changed to FOLFOX after induction CP
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: PET responders to induction FOLFOX during chemoradiation
Number of subjects: 241

Group type: COMPARATOR
Intervention: PET responders to induction CP during chemoradiation
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: PET responders to induction FOLFOX
Number of subjects: 241
Study: 33185339

Group type: EXPERIMENTAL
Intervention: Targeted antibiotic therapy
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Local peloid therapy
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Vibromagnetotherapy
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 124
Study: 35708162

Group type: EXPERIMENTAL
Intervention: Self‐criticism intervention
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Social media curation
Number of subjects: 130

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 130
Study: 34611700

Group type: EXPERIMENTAL
Intervention: Video-assisted anal fistula treatment (VAAFT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Fistulectomy and sphincter repair (FSR)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both groups (VAAFT and FSR)
Number of subjects: 45
Study: 32546278

Group type: EXPERIMENTAL
Intervention: 3,3′-diindolylmethane (DIM)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Celecoxib (COX2 selective inhibitor)
Number of subjects: 2

Group type: COMPARATOR
Intervention: PGE2 treatment
Number of subjects: 2

Group type: COMPARATOR
Intervention: Blockade of RhoA/ROCK1 pathway
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: DIM
Number of subjects: 2
Study: 34645251

Group type: EXPERIMENTAL
Intervention: Continuous renal replacement therapy (CRRT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intermittent hemodialysis (IHD)
Number of subjects: 120
Study: 32957420

Group type: EXPERIMENTAL
Intervention: Multicomponent physical exercise program with a Mediterranean diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 0
Study: 35969032

Group type: EXPERIMENTAL
Intervention: Selpercatinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cabozantinib or Vandetanib
Number of subjects: 0
Study: 33967255

Group type: EXPERIMENTAL
Intervention: PROVHILO strategy
Number of subjects: 20

Group type: COMPARATOR
Intervention: iPROVE strategy
Number of subjects: 20
Study: 32404378

Group type: EXPERIMENTAL
Intervention: High-salt diet (HSD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low-salt diet
Number of subjects: 20
Study: 36272105

Group type: EXPERIMENTAL
Intervention: Every-other-day strategy (EOD group)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Fertile window monitoring (FWM group)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 450
Study: 32871554

Group type: EXPERIMENTAL
Intervention: High-compression (HC) garments
Number of subjects: 10

Group type: COMPARATOR
Intervention: Loose-fitting gym attire (CON)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low-compression (LC) garments
Number of subjects: 10
Study: 33737653

Group type: EXPERIMENTAL
Intervention: Metabolomic biomarkers (valine, leucine, carnitine, glutamic acid)
Number of subjects: 1853

Group type: EXPERIMENTAL
Intervention: Leucine (confirmed by 2-sample Mendelian randomisation)
Number of subjects: 1853

Group type: EXPERIMENTAL
Intervention: Mendelian randomisation approach
Number of subjects: 1853

Group type: EXPERIMENTAL
Intervention: Valine and leucine
Number of subjects: 1853

Group type: EXPERIMENTAL
Intervention: Glutamic acid and alanine
Number of subjects: 1853
Study: 32113008

Group type: EXPERIMENTAL
Intervention: TG5 (trained at 5% of maximum voluntary isometric contraction of the PFM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: TG10 (trained at 10% of maximum voluntary isometric contraction of the PFM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: CG (control group, no specific training for the PFM)
Number of subjects: 30
Study: 34863994

Group type: EXPERIMENTAL
Intervention: Quercetin (1000 mg daily) + antiviral drugs (remdesivir or favipiravir)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Antiviral drugs (remdesivir or favipiravir)
Number of subjects: 60
Study: 33218517

Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education (PNE) program
Number of subjects: 30
Study: 35909493

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (rESWT) combined with conventional rehabilitation therapy (CRT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional rehabilitation therapy (CRT) alone
Number of subjects: 40
Study: 32746877

Group type: EXPERIMENTAL
Intervention: High-frequency chest wall oscillation (HFCWO)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-frequency chest wall oscillation (HFCWO) with recruitment manoeuvres (RM)
Number of subjects: 60
Study: 35103380

Group type: EXPERIMENTAL
Intervention: Health coach supervised by a virtual care team (high intensity)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Self‐directed learning (low intensity)
Number of subjects: 52
Study: 35320282

Group type: EXPERIMENTAL
Intervention: Conventional cytology
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Cell block preparation
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Combined conventional cytology and cell block preparation
Number of subjects: 166
Study: 32981337

Group type: EXPERIMENTAL
Intervention: Sodium reduction intervention
Number of subjects: 0
Study: 35726151

Group type: EXPERIMENTAL
Intervention: Anodal tDCS current applied over the primary motor cortex (M1) for 20 min at 2 mA
Number of subjects: 13

Group type: COMPARATOR
Intervention: SHAM intervention (current applied for 30 s then terminated)
Number of subjects: 13
Study: 33677529

Group type: EXPERIMENTAL
Intervention: Population Health Management (PHM) approach including electronic health record query, physician review, letter invitation, and telephone follow-up.
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Active respondents
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Passive respondents
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Study participants
Number of subjects: 599
Study: 32134854

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 34599663

Group type: EXPERIMENTAL
Intervention: Psychological treatment (specifics not provided)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Adjustment disorder (AD) diagnosis
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Employment status
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Time since diagnosis
Number of subjects: 200
Study: 32164888

Group type: EXPERIMENTAL
Intervention: Apixaban 2.5 mg twice daily
Number of subjects: 18073

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18073
Study: 35840916

Group type: EXPERIMENTAL
Intervention: MG plus A-MRI
Number of subjects: 198

Group type: COMPARATOR
Intervention: MG alone
Number of subjects: 198
Study: 33990939

Group type: EXPERIMENTAL
Intervention: 10-week martial arts training programme
Number of subjects: 283

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 283
Study: 32340075

Group type: EXPERIMENTAL
Intervention: Electrodiathermy
Number of subjects: 192

Group type: COMPARATOR
Intervention: Helium thermal coagulator
Number of subjects: 192
Study: 35384254

Group type: EXPERIMENTAL
Intervention: Dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent (DTS)
Number of subjects: 3146

Group type: COMPARATOR
Intervention: Sirolimus-eluting Orsiro stent (SES)
Number of subjects: 3146
Study: 32409485

Group type: EXPERIMENTAL
Intervention: Cenobamate 200 mg/d
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study: 36114009

Group type: COMPARATOR
Intervention: Seven additional vincristine and dexamethasone (VD) pulses (Control group)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: No additional vincristine and dexamethasone (VD) pulses (Experimental group)
Number of subjects: 263
Study: 34329984

Group type: EXPERIMENTAL
Intervention: HS+BT group (1,000 mg/kg betaine)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: HS group (no betaine)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (standard finisher feed under thermoneutral condition)
Number of subjects: 150
Study: 32182274

Group type: EXPERIMENTAL
Intervention: Tuberculin skin testing (TST) with induration cut-off ≥5mm
Number of subjects: 2985

Group type: EXPERIMENTAL
Intervention: Tuberculin skin testing (TST) with induration cut-off ≥10mm
Number of subjects: 2985

Group type: COMPARATOR
Intervention: Household contacts in Mangaung compared to Capricorn
Number of subjects: 2985

Group type: COMPARATOR
Intervention: Household contacts of HIV-positive index cases
Number of subjects: 2985
Study: 35373026

Group type: EXPERIMENTAL
Intervention: Ziltivekimab 15 mg subcutaneous injection
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ziltivekimab 50 mg subcutaneous injection
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ziltivekimab 5 mg subcutaneous injection
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 32532230

Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel plus ramucirumab (wPTX + RAM)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Weekly nab-paclitaxel plus ramucirumab (w-nab-PTX + RAM)
Number of subjects: 105
Study: 33524627

Group type: EXPERIMENTAL
Intervention: Single-row fixation
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Double-row suture bridge fixation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 68
Study: 32387214

Group type: EXPERIMENTAL
Intervention: Single Layer Intestinal Anastomosis (SLIA)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Double Layer Intestinal Anastomosis (DLIA)
Number of subjects: 106
Study: 35757181

Group type: EXPERIMENTAL
Intervention: Antioxidant supplement (NingXia RedⓇ), 60 ml daily for 60 days
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 155
Study: 32727335

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids and nano-curcumin combination
Number of subjects: 80

Group type: COMPARATOR
Intervention: n-3 fatty acids
Number of subjects: 80

Group type: COMPARATOR
Intervention: nano-curcumin
Number of subjects: 80

Group type: COMPARATOR
Intervention: n-3 fatty acids and curcumin placebo
Number of subjects: 80
Study: 35294298

Group type: EXPERIMENTAL
Intervention: Yoga breathing exercises (prāṇāyāma) over an observation period of 6 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no yoga intervention)
Number of subjects: 120
Study: 33099665

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate glue (n=216)
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Self-gripping mesh (n=202)
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Non-absorbable 3-0 polypropylene sutures (n=216)
Number of subjects: 625